Investor Participation

Multiple Law Firms Seek Lead Role in ADMA Biologics Securities Suit After Short‑seller Report

Plaintiff firms are soliciting investors to move for lead‑plaintiff status before an August 10 deadline as allegations about undisclosed related‑party sales and channel stuffing proceed in early litigation.